• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cullinan Therapeutics Inc (NQ: CGEM )

    19.91 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 19.91
    Bid (Size) 15.00 (10)
    Ask (Size) 23.41 (1)
    Prev. Close 19.91
    Today's Range 19.91 - 19.91
    52wk Range 7.640 - 30.19
    Shares Outstanding 199,873,683
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
    Objective response rate of 39% with manageable safety profile in patients with non-small cell lung cancer (NSCLC) harboring EGFR Exon 20 insertion mutations treated with zipalertinib who had progressed... 
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire
    Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +88.01%
    +88.01%
    1 Month
    +21.25%
    +21.25%
    3 Month
    +3.43%
    +3.43%
    6 Month
    +53.15%
    +53.15%
    1 Year
    +97.13%
    +97.13%

    More News

    Read More
    Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire
    Cullinan Oncology: Q4 Earnings Insights
    Via Benzinga
    CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q1 2024
    Via InvestorPlace
    Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire
    Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
    Via Benzinga
    Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
    Via Benzinga
    UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Cullinan Management Inc. (NASDAQ: CGEM) Records 52-Week High Tuesday Morning
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire
    Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
    From Cullinan Therapeutics, Inc.
    Via GlobeNewswire
    CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.